Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment

NCT06586320 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: 150% of their routine home dopaminergic medications dose right in the clinic
DEVICE: Evaluation of mathematical models

Sponsor

Stardots AB